Skip navigation



Sphere Fluidics Selected as a Finalist for 2018 Red Herring Top 100 Europe Award

Sphere Fluidics, a company providing single cell analysis systems underpinned by its patented picodroplet technology, announced today it has been selected as a finalist for Red Herring's Top 100 Europe award, a prestigious list honoring the year’s most promising private technology ventures from the European business region. More »
13 April 2018

Horizon Partners with Pirbright Institute to Support Research into Improvement of Vaccine Yields

Cambridge, UK, 12 April, 2018: Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “the Group”), a global leader in the application of gene editing and gene modulation to deliver inspired cell solutions, today announces that it has extended its biomanufacturing capabilities through an agreement with The Pirbright Institute to jointly work on a research program aimed at deploying cell engineering to increase the yields of livestock vaccines. More »
12 April 2018

Wickham Labs Announces Upcoming Webinar

Come join Wickham Laboratories and Patient Guard for this free webinar on May 23rd to discuss Regulatory Changes in Medical Device Development. More »
12 April 2018

Presentation of New Data on Inivata’s Industry-Leading Liquid Biopsy Platform at AACR 2018 Annual Meeting

Research Triangle Park, NC and Cambridge, UK, April 11, 2018 -- Inivata, a global clinical cancer genomics company utilizing an industry-leading liquid biopsy platform to transform patient care, announces that cutting-edge data on the performance of its liquid biopsy platform, InVision®, will be showcased in two oral presentations and two posters at the American Association for Cancer Research (AACR) Annual Meeting 14-18 April in Chicago. More »
11 April 2018

Owlstone Medical Provides Breath Biopsy Services to AstraZeneca

Cambridge, UK, April 9, 2018: Owlstone Medical, a diagnostics company developing a breathalyzer for disease, today announced it has signed a service agreement with AstraZeneca plc (LON: AZN), a global biopharmaceutical company. The collaboration will explore how breath can be used to identify novel biomarkers to help differentiate between disease phenotypes relevant for asthma and COPD. More »
11 April 2018

The RSA Group Strengthens Commitment to Swiss Life Sciences

The RSA Group, a leading Life Sciences executive search firm, is increasing its commitment to serving clients based in Switzerland. Thomas Schleimer, a Partner at The RSA Group will now also be working from the firm’s Basel office as the company expands its reach in the EMEA region. More »
11 April 2018

Business Lecture Explores 'Innovation in Education'

The next Cambridge Network business lecture on Tuesday 1st May explores 'Innovation in Education' - looking at how the fast-moving world of technology can provide resources and virtual environments to enable teachers and trainers to motivate and engage with their students. More »
10 April 2018

Job Fair Offers a World of Opportunity

Cambridge Network's next Job Fair on the afternoon of Friday 4th May promises jobseekers a huge variety of opportunity to connect with leading local employers. More »
10 April 2018

Apitope Announces Publication of Data in International Peer-Reviewed Journal Neurology

Apitope, a clinical stage biotech company developing potential first-in-class antigen-specific immunotherapies targeting autoimmune diseases, today announced publication of data on it multiple sclerosis treatment in Neurology, the official journal of the American Academy of Neurology and one of the world’s most widely read and highly cited peer-reviewed neurology medical journals. More »
09 April 2018

Inivata Publishes Results of Analytical Validation for InVisionFirstTM-Lung ctDNA Liquid Biopsy

Publication support robustness and reproducibility of the InVision™ platform Industry-leading sensitivity and specificity shown across all classes of genomic alterations relevant to non-small cell lung cancer More »
09 April 2018

<< Previous   Page 2 of 36   Next >>